Martin Deahl | Medicine | Best Researcher Award

Published on by Global Academic Awards

Prof. Martin Deahl | Medicine | Best Researcher Award

Institute of Psychiatry, Psychology & Neuroscience Library | United Kingdom

Prof. Martin Deahl has been recognized throughout his distinguished career with numerous prestigious honours and awards that reflect his excellence in research, clinical practice, teaching, and public service. As an undergraduate at St Bartholomew’s Hospital Medical College, he received the Senior Scholarship in Anatomy, Physiology and Biochemistry, the Herbert Patterson Prize in Biochemistry, the Slot Prize in Biochemistry, the Hungarian Prize in General Practice, the Jackson-Burrows Prize in Orthopaedics, the Joy and David Long Prize in Medicine, the Wheelwrights Prize in Paediatrics, and a Distinction in Medicine in his final MB.BS, all between 1980 and 1983. His postgraduate recognition includes the Denis Hill Prize in Psychiatry (1988) awarded for research excellence by the Institute of Psychiatry, University of London. Other significant accolades include an M.R.C. Travel Scholarship (1982), a commendation from the Chief Constable of British Transport Police for extraordinary public service during the King’s Cross fire (1988), Gulf War and Iraq campaign medals, the Liberation of Kuwait Medal, Freedom of the City of London, the Citizens Charter Award from the Department of Health for pioneering psychiatric service development, and repeated recognition as Best Teacher of Medicine (1994–2000). He has also received the Territorial Decoration, the Queen’s Commendation for Valuable Service (2005), Bronze and Silver UK National Clinical Excellence Awards (2002, 2007, renewed 2012), and, most notably, the Royal College of Psychiatrists President’s Medal in 2012 for outstanding services to psychiatry.

Profile: Orcid

Featured Publications

Deahl, M. (2025). Psychological trauma and the law…post-traumatic stress disorder (PTSD) or post-traumatic disorders (PTDs)? Is PTSD still fit for purpose? Medicine, Science and the Law.

Deahl, M. (2024). Are we selecting the right medical students? Journal of the Royal Society of Medicine.

Gwata, D., Ventriglio, A., Hughes, P., & Deahl, M. (2024). Structural inequalities, knife crime: A qualitative study. International Journal of Social Psychiatry.

Gwata, D., Ventriglio, A., Hughes, P., & Deahl, M. (2024). Youth violence and knife crime in ethnic minorities in the UK: A review of the literature. International Journal of Social Psychiatry.

Deahl, M., & Foster, P. (2024, December). Mr Bates and the post office: The implications of the UK post office scandal for the taxonomy of trauma. JRSM Open.

Mahmoud Ramadan | Medicine and Dentistry | Outstanding Scientist Award

Published on by Global Academic Awards

Assoc Prof Dr. Mahmoud Ramadan | Medicine and Dentistry | Outstanding Scientist Award

Associate Professor at College of Medicine, University of Sharjah, United Arab Emirates

Dr. Mahmoud Ramadan is an accomplished Clinical Associate Professor with extensive expertise in cardiovascular medicine and cardiology. He holds a Doctorate in Cardiovascular Medicine from Niigata University, Japan, and has been involved in various academic and clinical roles, currently serving at both the University of Sharjah in the UAE and Mansoura University in Egypt. With multiple certifications in cardiology and significant research experience, including participation in the global INTERHEART study, Dr. Ramadan has contributed numerous publications to esteemed journals. His proficiency in statistical analysis, languages, and various medical certifications underscores his dedication to advancing cardiovascular health and education.

Publication profile

Scopus Profile 

Education Background

Dr. Mahmoud Ramadan holds an extensive educational background in the field of medicine, particularly in cardiovascular medicine. He earned his Doctorate Degree in Cardiovascular Medicine from Niigata University Graduate School of Medical and Dental Sciences in Japan, graduating in September 2008. His doctoral thesis focused on the “Impact of Percutaneous Coronary Intervention on the Levels of Interleukin-6 and C-Reactive Protein in the Coronary Circulation of Subjects with Coronary Artery Disease.” Prior to this, he completed his Master’s degree in Cardiology at Mansoura University, Egypt, where he graduated in May 2001, and his undergraduate degree, M.B.B.Ch., from the same institution in November 1995, graduating with honors. Additionally, Dr. Ramadan has pursued further professional development, obtaining various certifications, including MRCP (UK) and other specialized courses in areas such as echocardiography, abdominal ultrasonography, and atherosclerosis, thereby reinforcing his expertise in the medical field.

Research Experience

Dr. Mahmoud Ramadan has extensive research experience in cardiovascular medicine, evidenced by his impactful work as a Clinical Associate Professor and multiple roles in renowned medical institutions. He earned his PhD from Niigata University, Japan, where he explored the effects of percutaneous coronary interventions on inflammatory markers in patients with coronary artery disease. His involvement in the global “INTERHEART” study significantly contributed to understanding myocardial infarction risk factors across various populations. Dr. Ramadan has published numerous original research articles in prestigious journals, focusing on topics such as cardiac dysfunction, coronary disease, and inflammatory responses, showcasing his dedication to advancing cardiovascular science. Additionally, he has supervised both master’s and PhD students, further demonstrating his commitment to fostering future research talent in the field.

Teaching and Mentoring Experience

Dr. Mahmoud Ramadan has extensive teaching and mentoring experience in the field of cardiology and medicine. As an Associate Professor of Medicine at the University of Sharjah and the Faculty of Medicine at Mansoura University, he has contributed significantly to the education of medical students and residents. He has lectured on various topics in cardiology, sharing his expertise and fostering critical thinking among students. Additionally, Dr. Ramadan has supervised numerous master’s and PhD students, guiding them through their research projects and dissertations, which demonstrates his commitment to nurturing the next generation of medical professionals. His role as an AHA-certified instructor in Advanced Cardiovascular Life Support (ACLS) and Basic Life Support (BLS) further underscores his dedication to teaching practical skills that are essential in clinical settings. Through his mentorship and teaching, he has played a vital role in shaping the educational landscape in cardiology, emphasizing the importance of both theoretical knowledge and hands-on experience.

Work Experience

Dr. Mahmoud Ramadan has an extensive work experience in the field of cardiology and medicine, spanning over two decades. He currently serves as an Associate Professor of Medicine in the Clinical Sciences Department at the University of Sharjah, UAE, and holds a similar position at Mansoura University in Egypt. His professional journey began as a House Officer at Mansoura University Hospitals, followed by various roles including Resident Physician, Assistant Lecturer, and Lecturer in Cardiology at Mansoura University. Throughout his career, he has engaged in advanced clinical training in Japan and contributed significantly to teaching, supervision, and research in cardiovascular medicine. Additionally, Dr. Ramadan is involved in multiple professional certifications, training programs, and has contributed to several international collaborative studies, showcasing his commitment to advancing medical knowledge and practice in cardiology.

Awards, Honours & Certificates

Dr. Mahmoud Ramadan has received several prestigious awards and honors throughout his academic and professional career. Notably, he was selected as a representative of Mansoura University in the global INTERHEART study, which was published in The Lancet. He also earned the esteemed Japanese Government Monbu-Kagakusho Scholarship for his PhD in Cardiology from Niigata University. In addition, Dr. Ramadan was recognized as a Young Investigator Award Finalist at the 22nd Annual Meeting of the Japanese Section of the International Society of Heart Research. His accolades include the EJISST Award at the First Egypt-Japan International Symposium on Science and Technology and the JSPS Post-Doctoral Fellowship from the Japan Society for the Promotion of Science in 2008. His commitment to continued education is evidenced by his completion of various certifications, including in mechanical ventilation and echocardiography, as well as his membership in several distinguished medical associations.

Publication Top Notes

  • Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
    • Authors: Brauer, M., Roth, G.A., Aravkin, A.Y., Murray, C.J.L., Gakidou, E.
    • Year: 2024
    • Citations: 66
  • Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
    • Authors: Ferrari, A.J., Santomauro, D.F., Aali, A., Vos, T., Murray, C.J.L.
    • Year: 2024
    • Citations: 107
  • Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement
    • Authors: Alsereidi, F.R., Khashim, Z., Marzook, H., Ramadan, M.M., Saleh, M.A.
    • Year: 2024
    • Citations: 4
  • Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
    • Authors: Sirota, S.B., Doxey, M.C., Dominguez, R.-M.V., Murray, C.J.L., Kyu, H.H.
    • Year: 2024
    • Citations: 1
  • Alchemilla vulgaris modulates isoproterenol-induced cardiotoxicity: interplay of oxidative stress, inflammation, autophagy, and apoptosis
    • Authors: Anajirih, N., Abdeen, A., Taher, E.S., Ramadan, M.M., Habotta, O.A.
    • Year: 2024
    • Citations: 0

Conclusion

Dr. Mahmoud Ramadan exemplifies the qualities of an outstanding researcher in cardiovascular medicine. His strong academic background, extensive research contributions, and clinical expertise make him a deserving candidate for the Best Researcher Award. By focusing on expanding his research scope, increasing outreach, diversifying research methodologies, and embracing innovative trends, he can further enhance his impact in the field. Awarding him this recognition would not only honor his past contributions but also encourage future advancements in cardiovascular research and patient care.

Gopal Natesan | Medicinal Chemistry | Best Researcher Award

Published on by Global Academic Awards

Prof Dr. Gopal Natesan | Medicinal Chemistry | Best Researcher Award

Prof Dr. Gopal Natesan, Institute of Pharmacy, Nirma University, India

Prof. Dr. Gopal Natesan is a distinguished academic and researcher in pharmaceutical chemistry, currently serving as Professor & Director at the Institute of Pharmacy, Nirma University, India. He holds a Ph.D. from Hamdard University and an MBA from MAHSA University. His research focuses on the synthesis of biologically active compounds and pharmacological evaluations. Dr. Natesan has received numerous accolades, including the “Most Trusted & Innovative Researcher in Asia” award in 2023 and the “Outstanding Scientist Award” in 2022. With a strong industrial background, he promotes research innovation and academic excellence. 🧪📚

Publication profile

Google Scholar

Educational Qualifications

Prof. Dr. Gopal Natesan boasts an impressive educational background. He earned his Ph.D. in Pharmaceutical Chemistry from Hamdard University in 2001. He also holds an M. Pharmacy from JSS College of Pharmacy (1996) and a B. Pharmacy from JKK Nataraja College of Pharmacy (1993), both affiliated with The Tamilnadu Dr. MGR Medical University. In 2016, he completed a Post Graduate Certificate in Teaching & Learning at Anglia Ruskin University, UK, and became a Fellow of The Higher Education Academy. Most recently, he obtained an MBA from MAHSA University in 2022. 📚🔬

 

Honors & Awards

Prof. Dr. Gopal Natesan has received numerous prestigious awards for his contributions to pharmaceutical science and education. In 2023, he was honored as the “Most Trusted & Innovative Researcher in Asia” at the ASIA-GCC Awards. His accolades include the “Outstanding Scientist Award” in 2022 and the “Edward Kennedy Memorial Award” in 2017. He has also received multiple best presentation and paper awards at international conferences, reflecting his commitment to excellence in research. Additionally, he was recognized with a Vice-Chancellor Award for outstanding performance in his MBA program, showcasing his academic prowess. 🌟🎓

 

Employment History

Prof. Dr. Gopal Natesan has served as Professor and Director at the Institute of Pharmacy, Nirma University, Ahmedabad, India. In this role, he manages operational activities, ensuring efficient administration and resource utilization. He oversees academic programs, maintaining high standards in teaching and curriculum development. Dr. Natesan is dedicated to faculty development, fostering continuous learning and research engagement. He enhances student experiences through support services and extracurricular activities while ensuring quality assurance through compliance with academic standards. Additionally, he promotes research innovation by securing grants and encouraging collaborations with industry and academia. 🌟🔬

Industrial Experience

Prof. Dr. Gopal Natesan has valuable industrial experience in the pharmaceutical sector. From November 2000 to January 2002, he worked as a Research Scientist at Ranbaxy Research Laboratory in Gurgoan, New Delhi, where he contributed to innovative pharmaceutical research. Following this, he served as a Research Associate at Orchid Chemicals & Pharmaceuticals Ltd in Chennai from January 2002 to February 2004. In these roles, he developed essential skills in research methodologies and project management, further enhancing his expertise in medicinal chemistry and pharmaceutical sciences. His industrial background complements his academic leadership, bridging theory and practice. 💼✨

 

Research Interests

Prof. Dr. Gopal Natesan specializes in medicinal chemistry, focusing on the synthesis and characterization of biologically active new chemical entities with five or six-member heterocyclic ring systems. His research includes the pharmacological evaluation of synthesized compounds, ensuring their potential therapeutic applications. Additionally, he is dedicated to the isolation and characterization of active constituents from plant sources, highlighting the importance of natural products in drug discovery. Dr. Natesan also explores pharmaceutical marketing management, integrating scientific research with practical applications in the pharmaceutical industry. 🌱💊

 

Publication Top Notes  

 

  • Hepatoprotective activity of Clerodendrum inerme against CCl4 induced hepatic injury in rats – Cited by: 85, Year: 2008 📄
  • Simultaneous estimation of paracetamol and aceclofenac in combined dosage forms by RP-HPLC method – Cited by: 44, Year: 2007 💊
  • Synthesis and Antibacterial Activity of Some Imidazole‐5‐(4H)one Derivatives – Cited by: 32, Year: 2005 🦠
  • Synthesis, characterization and antimicrobial activity of some novel Schiff and Mannich bases of isatin – Cited by: 22, Year: 2014 ✨
  • Antipyretic and analgesic effects of the aqueous extracts of Prosopis cineraria – Cited by: 22, Year: 2011 🌿
  • Quantitative estimation of lopinavir and ritonavir in tablets by RP-HPLC method – Cited by: 19, Year: 2012 💊
  • Simultaneous estimation of levocetirizine, ambroxol, phenylpropanolamine and paracetamol in combined dosage forms by RP-HPLC method – Cited by: 17, Year: 2006 📊
  • Anti-inflammatory activity of newly synthesised N-[4’-Oxo-2’-(substituted aryl/heteryl)-thiazolidin-3’-yl]-3-carboxamido-2H-chromen-2-one derivatives – Cited by: 15, Year: 2011 🔍
  • UV-Spectrophotometric Determination of Esomeprazole in tablet dosage forms – Cited by: 14, Year: 2007 💡
  • Effect of pollen substitute and two queen system on royal jelly production in Apis Mellifera L – Cited by: 13, Year: 1996 🐝
  • A validated HPTLC method for the estimation of donepezil HCL in bulk and its tablet dosage form – Cited by: 12, Year: 2011 ✔️
  • Synthesis and anticonvulsant activity of new 2-(substituted aryl/heteryl)-3-(substituted arylidenimino)-6, 8-dibromo-1, 2, 3, 4-tetrahydroquinazolin-4 (3H)-one derivatives – Cited by: 12, Year: 2006 ⚡
  • Synthesis and pharmacological evaluation of some indanone-3-acetic acid derivatives – Cited by: 11, Year: 2006 📈
  • UV spectrophotometric determination of famciclovir – Cited by: 10, Year: 2007 📊
  • Simultaneous determination of lafutadine and domperidone in capsule by high performance liquid chromatography – Cited by: 9, Year: 2012 💼

 

Pedro Antonio Regidor | Medicine and Dentistry | Best Innovation Award

Published on by Global Academic Awards

Dr. Pedro Antonio Regidor | Medicine and Dentistry | Best Innovation Award

Dr. Pedro Antonio Regidor, Exeltis, Germany

Dr. Pedro Antonio Regidor holds dual German and Spanish citizenship. He completed his medical studies at the University of Essen and gained extensive experience in gynecology and obstetrics across Germany and Venezuela. Notably, he served as Medical Director at Exeltis Europe and Global Projects. His qualifications include specialized certifications in radiological diagnostics and gynecological endocrinology. Dr. Regidor is recognized for his contributions to women’s health and medical innovation. Currently, he continues his work as a Medical Director and private practitioner in Munich, Germany. 🌍💉

Publication profile

Scopus

Professional Background

Dr. Pedro Antonio Regidor, holding both German and Spanish citizenship, has a distinguished career in the field of gynecology and obstetrics. His educational journey began at the Deutsche Schule Madrid and continued with medical studies at the University of Essen, where he completed his state exams and medical training. His professional experience spans multiple countries and prestigious institutions, including roles as a senior physician and medical director at prominent medical centers in Germany.

Innovative Contributions

Dr. Regidor has demonstrated a commitment to advancing medical practice and patient care. His roles in various high-profile positions, including Medical Director at Exeltis Europe & Global Projects, reflect his leadership in implementing innovative practices and advancing healthcare delivery. His experience with cutting-edge medical technologies and practices, including his certifications in advanced diagnostic and therapeutic techniques, underscores his contributions to medical innovation.

Awards and Recognitions

Dr. Regidor’s career is marked by several significant recognitions, including his certifications in specialized fields such as radiological diagnostics and gynecological endocrinology. His role as a Medical Director involved overseeing global projects, indicating a strong track record of managing and implementing innovative solutions across diverse healthcare settings.

Publication Top Notes

  • “The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users’ acceptability and newborn development” (Gynecological Endocrinology, 2024) 📅
  • “OPEN PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF A NEW VAGINAL PESSARY CONTAINING 300MG TINIDAZOLE, 200MG TIOCONAZOLE AND 100MG LIDOCAINE” (Reproductive Endocrinology, 2024) 📅
  • “Nausea and Vomiting of Pregnancy and its Management with the Dual-Release Formulation of Doxylamine and Pyridoxine” (Geburtshilfe und Frauenheilkunde, 2023) 📅
  • “Improvement in menopausal symptoms with a nutritional product containing evening primrose oil, hop extract, saffron, tryptophan, vitamins B6, D3, K2, B12, and B9” (European Review for Medical and Pharmacological Sciences, 2023) 📅
  • “10-month retrospective study on compliance and tolerability of the drospirenone-only pill” (European Review for Medical and Pharmacological Sciences, 2023) 📅
  • “Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and clinical results. Review of the literature” (Journal of Obstetrics and Gynaecology, 2023) 📅
  • “Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen” (Women’s Health, 2023) 📅
  • “The drospirenone (DRSP)-only pill: clinical implications in the daily use” (European Journal of Contraception and Reproductive Health Care, 2023) 📅
  • “Erratum: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone” (Geburtshilfe und Frauenheilkunde, 2022) 📅
  • “Evaluation of the food effect on a drospirenone only contraceptive containing 4 mg administered with and without high-fat breakfast in a randomised trial” (BMC Women’s Health, 2022) 📅


Conclusion

Dr. Pedro Antonio Regidor’s extensive experience in gynecology, his leadership in implementing innovative healthcare practices, and his significant contributions to medical advancements, he is a strong candidate for the “Research for Best Innovation Award.” His career reflects a profound impact on medical practices and innovation, aligning well with the award’s criteria.

 

 

 

 

 

 

 

 

Linette Thorn | Health Professions | Best Researcher Award

Published on by Global Academic Awards

Ms. Linette Thorn | Health Professions | Best Researcher Award

Ms. Linette Thorn, Aarhus University Hospital, Denmark

Based on Linette Thorn’s curriculum vitae, she appears to be a strong candidate for the “Research for Best Researcher Award.” Here’s a detailed evaluation of her qualifications:

Publication profile

Educational Background

Linette Thorn has a solid educational foundation, including a Master’s degree in Nursing Science from Aarhus University and intensive care nurse training. Her education is complemented by various specialized courses, such as NVivo and STATA, which underscore her commitment to advancing her research skills. 📚🎓

Professional Experience

With extensive experience in intensive care settings since 2007, Thorn’s roles span from intensive care nurse to project nurse in significant research projects. Her work with ICU-CogHab and ‘Live music in the ICU’ demonstrates a strong focus on innovative approaches to patient care. Her roles highlight her expertise in both clinical practice and research. 🏥🔬

Research Contributions

Thorn has been involved in notable research projects, including studies on live music’s impact in the ICU and cognitive rehabilitation for ICU patients. Her publications in peer-reviewed journals like the Australian Critical Care and International Journal of Qualitative Studies on Health and Well-being reflect a significant contribution to her field. Her research is funded by prestigious organizations, such as The Novo Nordisk Foundation. 📊🔍

Invited Speaker and Presentations

Her presentations at various international conferences, including the European Conference Culture for Health, showcase her ability to communicate complex research findings effectively. These speaking engagements reinforce her position as a thought leader in her field. 🎤🌍

Funding and Scholarships

Thorn has secured substantial funding for her research, including the Athena Award and project grants from The Novo Nordisk Foundation. This financial support is indicative of her research’s value and impact. 💰🏆

Publications

  • Collet, M.O., Nielsen, A.H., Larsen, L.K., Rahr, M.N., Svenningsen, H. (2024). Delirium and delirium severity screening in the intensive care—correspondence of screenings tools. Australian Critical Care, 37(3), pp. 407–413. 📅🔍
  • Dreyer, P., Thorn, L., Lund, T.H., Bro, M.L. (2024). Live music in the intensive care unit–a beautiful experience. International Journal of Qualitative Studies on Health and Well-being, 19(1), 2322755. 📅🎵
  • Nielsen, A.H., Larsen, L.K., Collet, M.O., Rahr, M.N., Svenningsen, H. (2023). Intensive care unit nurses’ perception of three different methods for delirium screening: A survey (DELIS-3). Australian Critical Care, 36(6), pp. 1035–1042. 📅🔍
  • Collet, M.O., Nielsen, G.M., Bang, B., Lange, T., Egerod, I. (2021). Does rocking motion calm delirious patients in ICU? A multicentre randomised clinical trial protocol (RockingICU). Acta Anaesthesiologica Scandinavica, 65(7), pp. 995–1001. 📅🪑

Conclusion

Linette Thorn’s extensive experience, impactful research, notable presentations, and successful funding applications position her as an exemplary candidate for the “Research for Best Researcher Award.” Her contributions to nursing research and patient care, combined with her strong academic and professional background, make her a deserving recipient of this honor. 🌟🎉

 

Neda Mostajeran | Pharmaceutical Science Award | Best Researcher Award

Published on by Global Academic Awards

Dr. Neda Mostajeran | Pharmaceutical Science Award | Best Researcher Award

Dr. Neda Mostajeran, Mashhad University of Medical Sciences, Iran

Dr. Neda Mostajeran is a Ph.D. candidate in Pharmaceutical Nanotechnology at Mashhad University of Medical Sciences, Iran. Her research focuses on innovative drug delivery systems including nanoliposomes, hydrogels, and nanofibers for applications in cancer therapy, wound healing, and ocular diseases. She has expertise in nanoformulations like liposomes and polymers, coupled with skills in tissue engineering and biochemical assays. With a background in Organic Chemistry and a strong publication record, she explores cutting-edge therapies such as non-coding RNA-based treatments. Driven by a passion for advancing healthcare through nanotechnology, she excels in scientific research, statistical analysis, and technical writing. 🧬

 

Publication profile

Professional Background

Dr. Neda Mostajeran is currently pursuing her Ph.D. in Pharmaceutical Nanotechnology at Mashhad University of Medical Sciences, Iran. Her research spans diverse areas including drug delivery systems, nano sensors, and hydrogel manufacturing, particularly focusing on nanoliposomes. She investigates factors influencing angiogenesis in cancer, wound healing, and ocular diseases, alongside exploring tissue engineering techniques for scaffold design like hydrogels and nanofibers. Her work extends to modern therapeutic nanosystems and the development of beads for localized osteomyelitis treatment. Proficient in MTT assay and HPLC, Dr. Mostajeran is dedicated to advancing nano-based drug delivery formulations such as liposomes, micelles, and polymers, with expertise in in-vitro biochemical and immunological assays. 🧪

Educational Achievements

 

Dr. Mostajeran holds a Master’s degree in Organic Chemistry from Islamic Azad University and a Bachelor’s in Chemistry from Kashan University. She possesses additional skills in statistical analysis, technical writing, communication, teaching, RT-PCR, and cell culture. 📚

 

Research Focus

Dr. Neda Mostajeran’s research primarily focuses on the design, solvent-free synthesis, and evaluation of antibacterial activity of coumarin sulfonamides. Her work, published in reputable journals like the Journal of the Iranian Chemical Society and Pharmaceutical Chemistry Journal, showcases her expertise in pharmaceutical chemistry and nanotechnology. Dr. Mostajeran collaborates extensively with peers on innovative approaches to synthesizing bioactive compounds and assessing their therapeutic potential, particularly in combating bacterial infections. Her contributions underscore a commitment to advancing drug discovery methodologies, integrating nanotechnology with organic chemistry to develop novel compounds that address significant health challenges. 🧪

 

Publication Top Notes

Design, solvent-free synthesis and antibacterial activity evaluation of new coumarin sulfonamides

Design, Solvent-Free Synthesis and Antibacterial Activity Evaluation of New Coumarine Sulfonamides

Solvent-Free Synthesis and Antibacterial Evaluation of Novel Coumarin Sulfonamides